In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Gilead Sciences, Inc (NASDAQ: GILD) closed at $89.14 down -1.64% from its previous closing price of $90.63. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 7.68 million shares were traded. GILD stock price reached its highest trading level at $90.6 during the session, while it also had its lowest trading level at $89.0.
Ratios:
For a deeper understanding of Gilead Sciences, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.16.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $110.
On November 14, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $125.Citigroup initiated its Buy rating on November 14, 2024, with a $125 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 19 ’24 when GILEAD SCIENCES, INC. bought 940,499 shares for $21.37 per share. The transaction valued at 20,098,464 led to the insider holds 2,209,471 shares of the business.
GILEAD SCIENCES, INC. bought 1,759,978 shares of GILD for $1,830,377 on Dec 18 ’24. The 10% Owner now owns 9,105,451 shares after completing the transaction at $1.04 per share. On Dec 16 ’24, another insider, Dickinson Andrew D, who serves as the Chief Financial Officer of the company, sold 8,500 shares for $91.96 each. As a result, the insider received 781,660 and left with 132,373 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GILD now has a Market Capitalization of 111092506624 and an Enterprise Value of 127560138752. As of this moment, Gilead’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1004.96, and their Forward P/E ratio for the next fiscal year is 11.79. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 107.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 6.01. Its current Enterprise Value per Revenue stands at 4.508 whereas that against EBITDA is 9.145.
Stock Price History:
Over the past 52 weeks, GILD has reached a high of $98.90, while it has fallen to a 52-week low of $62.07. The 50-Day Moving Average of the stock is -2.74%, while the 200-Day Moving Average is calculated to be 14.31%.
Shares Statistics:
For the past three months, GILD has traded an average of 6.41M shares per day and 4386620 over the past ten days. A total of 1.25B shares are outstanding, with a floating share count of 1.24B. Insiders hold about 0.10% of the company’s shares, while institutions hold 85.34% stake in the company. Shares short for GILD as of 1734048000 were 21977968 with a Short Ratio of 3.43, compared to 1731628800 on 18059419. Therefore, it implies a Short% of Shares Outstanding of 21977968 and a Short% of Float of 1.76.
Dividends & Splits
According to the company, the forward annual dividend rate for GILD is 3.08, from 3.06 in the trailing year. Against a Trailing Annual Dividend Yield of 0.033763655The stock’s 5-year Average Dividend Yield is 4.01.
